1998
DOI: 10.1002/(sici)1099-0690(199812)1998:12<2931::aid-ejoc2931>3.0.co;2-c
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Carbocyclic Homo-N-Nucleosides from Iridoids

Abstract: Two iridoid glucosides, antirrhinoside (1) and catalpol (2), were converted into selectively protected polysubstituted cyclopentylmethanols, which were subsequently used to prepare carbocyclic homo‐N‐nucleosides (5, 6 and 14). A purine moiety was introduced either by the Mitsunobu reaction or by substitution of a primary triflate with the tetrabutylammonium salt of 6‐iodopurine. The latter method was superior with regard to both ease of purification and yield. The N‐9 vs. N‐7 regioselectivity of the salts of d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

1999
1999
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 21 publications
0
9
0
Order By: Relevance
“…The observed instability of the triazine O -nucleoside analog 2 ( Scheme 1 ), prompted us to design the potentially more stable triazine homo- N -nucleoside analogs, 4 ( Figure 5 ). N -glycosidic nucleoside analogs represent a known, well established class of stable modified nucleosides [ 33 , 34 , 35 , 36 , 37 ]. For increased stability, the linking ether group was thus replaced by the corresponding –CH 2 -NH- linker.…”
Section: Resultsmentioning
confidence: 99%
“…The observed instability of the triazine O -nucleoside analog 2 ( Scheme 1 ), prompted us to design the potentially more stable triazine homo- N -nucleoside analogs, 4 ( Figure 5 ). N -glycosidic nucleoside analogs represent a known, well established class of stable modified nucleosides [ 33 , 34 , 35 , 36 , 37 ]. For increased stability, the linking ether group was thus replaced by the corresponding –CH 2 -NH- linker.…”
Section: Resultsmentioning
confidence: 99%
“…Compound 17a was prepared by TBDMS-protection of diol 6, mesylation of the resulting compound 14, and replacement of the mesyl group of 15 with chloropurinyl in analogy to the preparation of 10 from 9. In view of the reported preparation of methylene-linked nucleoside analogues by reaction between the tetrabutylammonium salt of 6-chloropurine and a primary triflate, 12 we also tried to obtain 17a by generating the triflate of pseudosugar 14 (compound 18) and treating it with the Bu 4 N + salt in question, but the yield of 17a obtained by this method never exceeded 8%.…”
Section: Figurementioning
confidence: 99%
“…This concentrate was stirred with 4 Å molecular sieves (ca. 2.5 g) for 1 h at 0 ºC, and then treated with the tetrabutylammonium salt of 6-chloropurine (0.27 mg, 0.68 mmol), previously prepared from 6-chloropurine as described Franzyk et al 12 Stirring was continued for 64 h at -10 ºC, after which the mixture was filtered and the filtrate was concentrated to dryness, leaving a residue (0.57 g) that was fractionated on a silica gel column using hexane-EtOAc (1:1), hexane-EtOAc (1:3) and 2% MeOH-EtOAc as successive eluents. The middle fractions afforded 17a (27 mg, 8%) as a white solid with spectroscopic data identical to those of the compound obtained by Method A.…”
Section: Compound 17amentioning
confidence: 99%
“…In the series of 2′- or 3′-hydroxymetyl cyclopentane -1′-homocarbanucleosides, a few compounds presented a slight antiviral or anticancer activity [18,19], while 1′,3′-disubstituted cyclopentene analogs [20] or 2′,3′- cis diols [21], were found to be inactive. Other analogs synthesized had low or no antiviral activity [22,23,24], with the exception of the adenine analog [24]. However, a few chemical structures were fruitfully used to obtain active 1′-homocarbanucleosides (Figure 2), like for example: V , with a 2,2,3-trimethylcyclopentanol, active against HIV-1 and HIV-2 at an EC 50 = 4–14 µg/mL [25,26].…”
Section: Introductionmentioning
confidence: 99%